Amylin acquires Restoragen CHF compound

AMLN acquired from Restoragen (Lincoln, Neb.) rights to a continuous infusion formulation of glucagon-like peptide 1 (GLP-1), which is in Phase II testing to treat congestive heart failure (CHF) patie...